Trajenta Duo 2.5/500mg (Linagliptin/Metformin)

Product Overview

Trajenta Duo 2.5/500mg is an oral combination medicine that contains two active ingredients:

• Linagliptin 2.5 mg
• Metformin Hydrochloride 500 mg

The medication is used for the control of type 2 diabetes mellitus to improve the control of blood sugar levels, even when exercise and diet are not enough.

Linagliptin is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor that boosts the level of incretin hormones. It also helps boost insulin production and lower the secretion of glucagon in a glucose-dependent way.

Metformin is a biguanide that reduces blood glucose principally by decreasing hepatic glucose production and enhancing the sensitivity of insulin.

The combination of these two therapies targets several pathways to manage diabetes, improving glycemic control and minimising the chance of hypoglycemia.

Composition

• Linagliptin: 2.5 mg
• Metformin Hydrochloride: 500 mg (immediate-release or extended-release depending on formulation)
• Form: Oral tablet

Indications

Trajenta Duo is indicated for:

• Adults who suffer from type 2 diabetes mellitus are not adequately controlled through exercise and diet.
• Patients who need a combination therapy of metformin and linagliptin to improve glucose control.
• It is often prescribed when monotherapy using metformin, linagliptin, or both isn’t enough.

Mechanism of Action

Linagliptin

• It blocks the enzyme DPP-4, which is responsible for degrading the incretin hormones (GLP-1 as well as GIP).
• Incretin-related activity is prolonged, which increases levels of insulin release after eating.
• Reduces the release of glucagon, which in turn reduces the release of glucose from the liver.

Metformin

• Hepatic glucose production is reduced.
• It increases peripheral glucose absorption and utilization.
• Increases insulin sensitivity, but not levels of insulin.

This double mechanism enables more control of the fasting as well as postprandial blood glucose levels.

Dosage and Administration

• Usually, taken every day, either once or twice, along with meals to minimize side effects on digestion.
• The dosage is based on the patient’s requirements, kidney function, and the treatment response.
• The tablet is best taken whole and dissolved in water. Don’t crush or chew.
• Dosage adjustment is dependent on the monitoring of blood sugar and the tolerability.
• Metformin’s maximum dosage typically ranges from 2000 to 2500 mg daily (depending on the formula).

Side Effects

Common Side Effects

• Gastrointestinal issues like nausea and vomiting, diarrhea, and stomach discomfort (mainly caused by metformin)
• Headache
• Infections of the upper respiratory tract
• Hypoglycemia (rare when used without insulin or sulfonylureas)
• Nasopharyngitis

Serious Side Effects (Rare)

• Lactic acidosis: An uncommon but severe metabolic disorder that is linked to metformin. It is characterized by muscular pain, weakness, breath difficulties, an unusually fatigue.
• Severe allergic reactions: rash, swelling, or difficulty breathing.
• Pancreatitis (inflammation of the pancreas), can be manifested as intense abdominal pain.
• The risk of developing hypoglycemia is increased when combined with other drugs to reduce glucose.

Precautions and Warnings

• Kidney function: Metformin is not recommended for those with severe impairment of the kidneys. The kidney function must be evaluated before starting treatment and regularly throughout the treatment.
• Liver disease: Be cautious, as liver disease increases the chance of developing lactic acidosis.
• Heart failure: Pay attention to your surroundings due to the higher chance of developing hypoxia.
• Alcohol: Excessive alcohol consumption can increase the risk of developing lactic acidosis.
• Contrast dyes: Metformin must be stopped temporarily before imaging that uses iodinated contrast medium.
• Hypoglycemia risk: Increased when using the insulin drug or with sulfonylureas.
• Pregnancy and breastfeeding: Make use of it only when the benefits exceed the risks. Consult a physician.

Drug Interactions

• Cimetidine, ranitidine: Might increase the levels of metformin.
• Diuretics, corticosteroids: Could increase blood sugar.
• Other antidiabetic drugs: The risk of developing hypoglycemia increases.
• Rifampicin and carbamazepine: Could reduce the effectiveness of linagliptin.
• Medications affecting kidney function: Require caution.

Make sure you inform your physician of any medication you take, not just supplements.

Missed Dose and Overdose

Missed Dose:

• Do not miss the dose as soon as possible.
• If it is close to the time of the next dose, avoid the dose you missed.
• Do not take double dosages.

Overdose:

• Symptoms may include severe nausea, vomiting, abdominal pain, hypoglycemia, or lactic acidosis.
• Get medical attention immediately when you suspect an overdose.

Storage Instructions

• Keep it below 30°C in a dry location.
• Be sure to shield yourself from light and moisture.
• Be sure to keep away from youngsters.
• Do not use after expiry date.

FAQs – Trajenta Duo 2.5/500 mg

What is Trajenta Duo used for?

It helps increase blood sugar control for those with type 2 diabetes when the diet and exercise do not suffice.

How does it work?

Linagliptin enhances insulin sensitivity and lowers glucagon production, while metformin decreases the production of glucose in the liver and increases insulin sensitivity.

How should I take Trajenta Duo?

Do it once or twice a day during meals. Take the tablet as a whole and swallow it with water.

Can Trajenta Duo cause low blood sugar?

Hypoglycemia risk is minimal for use on its own, but it can be increased when combined with insulin or Sulfonylureas.

What are common side effects?

Headache, nausea, diarrhea, and respiratory illnesses are typical. Negative effects such as lactic acidosis are not common.

Can I drink alcohol while on this medication?

The consumption of alcohol increases the chance of developing lactic acidosis, and it is best avoided or restricted.

Is this medication safe during pregnancy?

See your doctor. Benefits and dangers must be considered with care.

Do I need to monitor my blood sugar?

Yes, indeed, frequent monitoring of blood glucose is essential for assessing the effectiveness of treatment and altering dosage.

What should I do if I miss a dose?

Use it as fast as you can, unless it is near your next dose. Don’t take more than one dose.

Can I take other diabetes medications with Trajenta Duo?

Yes, however, you must always consult your physician, since doses as well as the risk of hypoglycemia could require adjustment.

Conclusion

Trajenta Duo 2.5/500 mg (Linagliptin/Metformin) is an effective combination therapy for managing type 2 diabetes by targeting multiple mechanisms to control blood glucose. It is convenient and provides improved glycemic control, particularly when monotherapy is not sufficient.

Patients must adhere to the dosages prescribed, check their blood sugar frequently, and report any reactions or problems for optimal treatment results.